| | |
| Names | |
|---|---|
| IUPAC name (2S,6S)-6-Amino-6-carbamoyl-2-[(4R)-4-carboxy-4-[(2R)-2-dodecanamidopropanamido]butanamido]hexanoic acid | |
| Identifiers | |
| |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C27H49N5O8 | |
| Molar mass | 571.716 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Tabilautide is an immunological agent. It was studied as a potential drug for the treatment of cancer, but development for this purpose has been discontinued. [1]